Compare PASG & MBBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PASG | MBBC |
|---|---|---|
| Founded | 2017 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 29.3M | 33.5M |
| IPO Year | 2020 | N/A |
| Metric | PASG | MBBC |
|---|---|---|
| Price | $9.95 | $11.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $34.50 | N/A |
| AVG Volume (30 Days) | ★ 46.5K | 7.7K |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.11 |
| Revenue | N/A | ★ $7,299,708.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $101.88 |
| Revenue Growth | N/A | ★ 7.77 |
| 52 Week Low | $5.12 | $7.47 |
| 52 Week High | $20.20 | $12.89 |
| Indicator | PASG | MBBC |
|---|---|---|
| Relative Strength Index (RSI) | 58.90 | 50.63 |
| Support Level | $9.72 | $11.09 |
| Resistance Level | $10.71 | $11.61 |
| Average True Range (ATR) | 0.84 | 0.21 |
| MACD | 0.11 | -0.02 |
| Stochastic Oscillator | 73.08 | 27.94 |
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.
Marathon Bancorp Inc is a mid-tier holding company for Marathon Bank, a Wisconsin-chartered savings bank. The group operates as a community-oriented bank offering a variety of financial products and services to meet the needs of customers. The primary deposit products are demand deposits, savings, and certificates of deposits; and prime lending products are commercial real estate, commercial and industrial, construction, one-to-four-family residential, multifamily real estate, and consumer loans. The majority of the group's revenue comes from interest income on loans and debt securities.